<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04505852</url>
  </required_header>
  <id_info>
    <org_study_id>CF19347A</org_study_id>
    <nct_id>NCT04505852</nct_id>
  </id_info>
  <brief_title>Implementing Artificial-intelligence Wristbands to Help in Recording Seizures</brief_title>
  <official_title>Implementing Artificial-intelligence Wristbands to Help in Recording Seizures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taichung Veterans General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that the participants will be satisfied with&#xD;
      artificial-intelligence wristband Embrace&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, seizure tracking relies on subjective patient and family recall. In several&#xD;
      studies patients report only approximately half of their seizures, and even less during&#xD;
      sleep.&#xD;
&#xD;
      Sudden unexplained death in epilepsy (SUDEP) is the cause of premature death of up to 17% of&#xD;
      all patients with epilepsy and as many as 50% with chronic refractory epilepsy (with rates as&#xD;
      high as 1% per year). Its etiology is probably due to peri-ictal respiratory, cardiac, or&#xD;
      autonomic nervous system dysfunction.&#xD;
&#xD;
      Wristband sensors help caregivers assist patients during seizures and may reduce risks for&#xD;
      complications such as injuries and SUDEP.&#xD;
&#xD;
      Accurate seizure detection may improve the quality of life (QoL) of subjects and caregivers&#xD;
      by decreasing burden of seizure monitoring and may facilitate diagnostic monitoring in the&#xD;
      home setting. Possible risks are occurrence of alarm fatigue and invasion of privacy.&#xD;
&#xD;
      The wristband Embrace has an overall sensitivity of 89.1% and an overall specificity of&#xD;
      93.1%. The investigators hypothesize that the participants will be satisfied with&#xD;
      artificial-intelligence wristband Embrace.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      When the smart wristband detects the seizure, the mobile phone sends a text message to the&#xD;
      companion and the nurse, the latter will see or get in touch with the companion and keep a&#xD;
      record.&#xD;
&#xD;
      In-patients receiving video-electroencephalography (VEEG) exam use Embrace during the VEEG&#xD;
      recording which usually takes 3-5 days.&#xD;
&#xD;
      Out-patients use Embrace for 8 weeks. The investigators will enroll 30-50 patients, half&#xD;
      in-patients and half out-patients.&#xD;
&#xD;
      The benefits are evaluated in terms of satisfaction. .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction score of seizure wristband</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Scores 1(least satisfied) to 10 (most satisfied)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>EMBRACE USERS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Embrace wristband users</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Embrace</intervention_name>
    <description>Patients wear Embrace2 to help in seizure reporting and patient care.</description>
    <arm_group_label>EMBRACE USERS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least one seizure per month in the 3-month period before entering the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncountable seizures, psychogenic seizures, alcohol or drug abuse, severe heart or&#xD;
             lung disorder, rapid progressive brain disorder, life-terminal disease, severe&#xD;
             infection/ bleeding/ liver/ kidney disorder, platelet &lt;80,000/μL, neutrophil&#xD;
             &lt;1,000/μL, clinically significant ECG abnormality, unstable psychiatric disease&#xD;
             (except anxiety).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PEIYUAN F. HSIEH, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taichung Veterans General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PEIYUAN F. HSIEH, MD</last_name>
    <phone>886-4-23592525</phone>
    <phone_ext>3021</phone_ext>
    <email>pfhsieh@vghtc.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>40705</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 5, 2020</study_first_submitted>
  <study_first_submitted_qc>August 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taichung Veterans General Hospital</investigator_affiliation>
    <investigator_full_name>PEIYUAN F. HSIEH</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

